Having trouble viewing this email? View in your browser.
ESCMID Logo

11 October 2016
WEEKLY NEWS

Dear colleagues,

ESCMID published a press release on the conference it organized with ASM to present new strategies and tactics to fight antimicrobial resistance.

Best regards, your ESCMID communications editors

 

Last call: research grant applications accepted until 13 October

Applications for next year’s ESCMID research grants are accepted until 13 October 2016 at 12:00 noon CET. For the 2017 grants we only accept proposals for projects on fungal/viral/parasitic infections and diseases (including diagnostics, pathogenesis, susceptibility, resistance, stewardship and vaccines). This focus increases the chances of individual projects. In addition to the regular EUR 20,000 grants, ESCMID has reserved up to EUR 50,000 each for two excellently rated projects.

› Read more
 

CMI highlight: Multidrug-resistant tuberculosis and migration in Europe

Researchers led by a team at the Imperial College London studied the impact of migration on multidrug-resistant tuberculosis (MDR-TB) in low-incidence countries in Europe. The study showed that a significant proportion of MDR-TB cases in migrants result from reactivation of latent infection. Screening, however, is highly problematic since current tests cannot distinguish latent MDR-TB. Although there is a human rights obligation to improve the diagnosis, treatment, and prevention of MDR-TB in migrants, refugees experience significant barriers to testing and treatment, exacerbated by increasingly restrictive health systems. The researchers call for further studies into the impact of screening on detection or prevention, and the potential consequences of failing to treat and prevent MDR-TB among migrants in Europe. An evidence-based guidance for treatment of latent infection and effective approaches for MDR-TB management are urgently needed, the researchers conclude.

› Read more
 

Trainee Association publishes results of survey among CM/ID trainees

The Trainee Association of ESCMID (TAE) has recently published the results of a large survey among European trainees in clinical microbiology and infectious disease on training systems and training adequacy. This survey shows high heterogeneity in training conditions in European countries, identifies perceived gaps in training, and suggests areas for improvements. You may find the results in the open-access article.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.